Many studies are actually conducted to target IL-17 in arthritis models [62,63] because of its potential synergistic effects with IL-1β, IL-6, and TNF-α in inducing cytokine expression and joint damage [64]. The gene discussed is IL6; the disease is arthritic joint disease.